NCT03336359

Brief Summary

This is a prospective randomized trial comparing the adenoma detection rate of LCI with NBI. Eligible patients are randomly allocated in a 1:1 ratio to undergo tandem colonoscopy with LCI (LCI group) or NBI (NBI group). Randomization will be carried out by computer generated random sequences and stratified according to endoscopist's experiences (experienced versus fellows) and indications of colonoscopy (symptomatic vs screening/surveillance). The primary outcome of this study is to compare the adenoma or polyp detection rates by LCI and NBI during the first examination. Secondary outcomes included adenoma/polyp miss rate by LCI or NBI. Other outcomes include sessile serrated adenomas or polyps (SSA/P) detection rates and advanced adenoma detection rates.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
272

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 23, 2017

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

November 5, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 8, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

April 17, 2019

Status Verified

April 1, 2019

Enrollment Period

11 months

First QC Date

November 5, 2017

Last Update Submit

April 15, 2019

Conditions

Keywords

colonoscopyimage enhanced endoscopy

Outcome Measures

Primary Outcomes (1)

  • Adenoma/polyp detection rate

    Percentage of patients with adenoma/polyp detected

    first-pass colonoscopy

Secondary Outcomes (1)

  • Adenoma/polyp miss rate

    second-pass colonoscopy

Other Outcomes (2)

  • advanced adenoma detection rate

    first-pass colonoscopy

  • SSA detection rate

    first-pass colonoscopy

Study Arms (2)

LCI

ACTIVE COMPARATOR

Tandem colonoscopy with Linked Color Imaging system

Diagnostic Test: Tandem colonoscopy

NBI

ACTIVE COMPARATOR

Tandem colonoscopy with Narrow band imaging system

Diagnostic Test: Tandem colonoscopy

Interventions

Tandem colonoscopyDIAGNOSTIC_TEST

Different image enhanced endoscopy systems

LCINBI

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consecutive adult patients undergoing outpatient colonoscopy
  • aged 40 or above

You may not qualify if:

  • unable to provide informed consent
  • have undergone previous colorectal resection
  • personal history of colorectal cancer, inflammatory bowel disease, familial adenomatous polyposis, Peutz-Jeghers syndrome, or other polyposis syndromes
  • considered to be unsafe for polypectomy including patients with bleeding tendency and those with severe comorbid illnesses
  • cecum could not be intubated for various reasons or due to poor bowel preparation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Mary Hospital

Hong Kong, China

Location

Related Publications (1)

  • Leung WK, Guo CG, Ko MKL, To EWP, Mak LY, Tong TSM, Chen LJ, But DYK, Wong SY, Liu KSH, Tsui V, Lam FYF, Lui TKL, Cheung KS, Lo SH, Hung IFN. Linked color imaging versus narrow-band imaging for colorectal polyp detection: a prospective randomized tandem colonoscopy study. Gastrointest Endosc. 2020 Jan;91(1):104-112.e5. doi: 10.1016/j.gie.2019.06.031. Epub 2019 Jul 2.

Study Officials

  • Wai K Leung, MD

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 5, 2017

First Posted

November 8, 2017

Study Start

October 23, 2017

Primary Completion

September 20, 2018

Study Completion

December 31, 2018

Last Updated

April 17, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

Locations